iqvia semaglutide tirzepatide prescriptions q3 2024 us iqvia glp-1 prescriptions q3 2024 semaglutide tirzepatide Prescriptions Are Up, Health Services Utilization Down, and GLP-1s Are a Major Growth Driver: IQVIA's 2024 Update-bsmoothhr Momentum is building for oral

The key findings provide the most reliable timeline for expected results: Week 4: Average weight loss of approximately 1 to 2% of body weight Week 12: Average weight loss of approximately 5 to 6% of body weight Week 20: Average weight loss of approximately 10% of body weight Week 40: Average weight loss of approximately 13 to 14% of body weight Week 68: Average weight loss of approximately 15 to 17% of body weight These are averages, meaning some participants lost more and some lost less

Related Reading Tirzepatide For Weight Loss 2 Glp 1 Dosage For Weight Loss Tirzepatide Vs Semaglutide For Weight Loss Tirzepatide For Weight Loss Pricing and availability current as of June 2026

Exercise: Begin light activities like walking or yoga to build consistency

SELECT demonstrated that add-on treatment with Wegovy clearly provided additional cardiovascular protection